Public health clinic-based hepatitis C testing and linkage to care in Baltimore.

scientific article published on 3 February 2016

Public health clinic-based hepatitis C testing and linkage to care in Baltimore. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/JVH.12507
P932PMC publication ID4836954
P698PubMed publication ID26840570

P50authorCarl LatkinQ64481885
Oluwaseun Falade-NwuliaQ82728624
Shruti H MehtaQ85470954
Alexander NiculescuQ87219036
David L ThomasQ89653947
Mark SulkowskiQ89653950
P2093author name stringK R Page
C O'Connor
P Chaulk
J Lasola
K Ghanem
P2860cites workDevelopment of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--IIQ28260514
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002Q29619974
Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United StatesQ33819963
The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysisQ33837518
Mental and physical symptoms associated with lower social support for patients with hepatitis C.Q33867829
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.Q34294185
Barriers to the treatment of hepatitis C. Patient, provider, and system factorsQ34723678
Changes in blood-borne infection risk among injection drug usersQ34772870
The costs and impacts of testing for hepatitis C virus antibody in public STD clinicsQ35696958
Is there an association between alcohol consumption and sexually transmitted diseases? A systematic reviewQ36053457
Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008Q36100389
Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment programQ36421892
Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002.Q36579571
The relationship between recent alcohol use and sexual behaviors: gender differences among sexually transmitted disease clinic patientsQ36986655
Racial differences in hepatitis C treatment eligibilityQ37077462
Racial disparity in liver disease: Biological, cultural, or socioeconomic factorsQ37095472
Limited uptake of hepatitis C treatment among injection drug usersQ37238205
Hepatitis C virus control among persons who inject drugs requires overcoming barriers to careQ37358615
The new paradigm of hepatitis C therapy: integration of oral therapies into best practicesQ37455611
Patients attending STD clinics in an evolving health care environment. Demographics, insurance coverage, preferences for STD services, and STD morbidityQ38554928
Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating servicesQ39563257
Hepatitis C seroprevalence and risk behaviors in patients attending sexually transmitted disease clinicsQ39639028
Integrating viral hepatitis prevention services into an urban STD clinic: Denver, ColoradoQ39799454
The continuum of hepatitis C testing and care.Q40231197
Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United StatesQ40786866
Identification and Linkage to Care of HCV-Infected Persons in Five Health Centers - Philadelphia, Pennsylvania, 2012-2014.Q40966047
Hepatitis B and hepatitis C in emergency department patientsQ42069509
Integrating viral hepatitis prevention into STD clinics in Illinois (excluding Chicago), 1999-2005.Q42732026
Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C.Q42988446
Hepatitis C in the United StatesQ42992102
Significant reductions in drinking following brief alcohol treatment provided in a hepatitis C clinicQ43120673
The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.Q44979610
Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and PreventionQ45355364
Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseasesQ45778719
AUDIT-C as a brief screen for alcohol misuse in primary care.Q51756065
Hepatitis C testing, infection, and linkage to care among racial and ethnic minorities in the United States, 2009-2010Q64128181
P433issue5
P921main subjecthepatitis CQ154869
public healthQ189603
P304page(s)366-374
P577publication date2016-02-03
P1433published inJournal of Viral HepatitisQ15749962
P1476titlePublic health clinic-based hepatitis C testing and linkage to care in Baltimore
P478volume23

Reverse relations

cites work (P2860)
Q98892424Accelerating the elimination of hepatitis C in Kuwait: An expert opinion
Q64897566Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore.
Q58603844Comparison of hepatitis C virus testing recommendations in high-income countries
Q38613271Direct-acting antiviral agents for HCV infection affecting people who inject drugs
Q40118647Directly observed therapy of sofosbuvir/ribavirin +/- peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT).
Q91899720Disparities in Hepatitis C Linkage to Care in the Direct Acting Antiviral Era: Findings From a Referral Clinic With an Embedded Nurse Navigator Model
Q57301030Economic Comparison of Serologic and Molecular Screening Strategies for Hepatitis C Virus
Q64237696Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs
Q90682036Hepatitis C Screening: Barriers to Linkage to Care
Q38961563Hepatitis C Treatment and Barriers to Eradication
Q57166986Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework
Q38906623Improving support and education of low-income baby boomers diagnosed with chronic hepatitis C virus infection through universal screening.
Q90067192Individual and network factors associated with HCV treatment uptake among people who inject drugs
Q64936868Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system.
Q33717043Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility
Q56891090Monitoring the hepatitis C care cascade using administrative claims data
Q88780662Pay It Forward: Building Capacity to Treat Hepatitis C by Training Our Own Residents
Q91908431Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE Study
Q98895261Persistent Challenges in the Hepatitis C Virus Care Continuum for Patients in a Central Texas Public Health System
Q37573484Primary Care Providers Knowledge, Attitude and Practices Related to Hepatitis C Screening and Treatment in the Oral Direct Acting Antiviral Agents Era.
Q59352236Race and Hepatitis C Care Continuum in an Underserved Birth Cohort
Q38661825Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Q55429477Sample-to-Answer Droplet Magnetofluidic Platform for Point-of-Care Hepatitis C Viral Load Quantitation.
Q36858828Strategies for Expanding Access to HBV and HCV Testing and Care in the United States: The CDC Hepatitis Testing and Linkage to Care Initiative, 2012-2014
Q64132787The Hepatitis C Virus Care Continuum: Linkage to Hepatitis C Virus Care and Treatment Among Patients at an Urban Health Network, Philadelphia, PA